Clinical Trial Update: Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating rosuvastatin for dose optimization in early-stage and metastatic estrogen receptor-positive breast cancer patients on endocrine th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Duke University | Conditions: Breast Cancer | Phase 1 | Status: WITHDRAWN